Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-14

Clinical Trial Update: The Paediatric EVICEL® Neuro Study [Phase 3]

View source ↗

Summary

Phase 3 pediatric study of EVICEL for cerebrospinal fluid leak was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evicel

Snippet

Sponsor: Ethicon, Inc. | Conditions: CSF Leak | Phase 3 | Status: TERMINATED | Results posted: 2023-07-14